News
Vinay Prasad, a top regulator at the US Food and Drug Administration, ended his short tenure at the agency after conservative ...
But this time, the unknown is hitting the industry in a different way from when Prasad was tapped to lead CBER less than ...
TipRanks on MSN18h
Sarepta Stock (SRPT) Rallies on FDA Nod for Broader Gene Therapy Use
Shares of Sarepta Therapeutics ($SRPT) jumped over 14% on Tuesday after the FDA authorized the company to restart shipments ...
GlobalData on MSN22h
Prasad’s FDA exit may accelerate cell and gene therapy approvals
Vinay Prasad, head of the Center for Biologics Evaluation and Research (CBER) at the US Food and Drug Administration (FDA), ...
17hon MSN
Trump drove firing of FDA official
The president overruled his HHS secretary and FDA chief, four people with knowledge of the decision tell POLITICO.
Donald Trump reportedly ignored calls from Health Secretary Robert F. Kennedy Jr. not to fire the top vaccine official at the Food and Drug Administration after a pressure campaign from far-right ...
The former official, Vinay Prasad, had been on the job three months and had recently come under attack by conservative ...
In a 51–47 vote along party lines, the Senate confirmed Monarez as the director of the Centers for Disease Control and ...
The abrupt exit of the former CBER director, who quickly made his mark at the agency with several high-profile and ...
Hong Kong-based CSPC will receive $120 million from Madrigal under the deal. Elsewhere, Apellis and PTC Therapeutics won FDA ...
Investors braced for the Federal Reserve's next interest rate decision and earnings from tech giants Microsoft and Meta.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback